Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Apr;25(2):174-183.
doi: 10.1177/1358863X19884130. Epub 2019 Dec 5.

A review of endovascular stenting for superior vena cava syndrome in fibrosing mediastinitis

Affiliations
Review

A review of endovascular stenting for superior vena cava syndrome in fibrosing mediastinitis

Himanshu Deshwal et al. Vasc Med. 2020 Apr.

Abstract

Fibrosing mediastinitis (FM) is a rare disorder of inflammation and fibrosis involving the mediastinum. The formation of fibroinflammatory mass in the mediastinum can lead to obstruction of mediastinal structures and cause severe debilitating and life-threatening symptoms. Superior vena cava syndrome (SVCS) is a dreaded complication of FM with no medical therapy proven to be efficacious. Spiral vein grafting has long been utilized as first-line therapy for SVC syndrome due to FM. Endovascular repair with stents and angioplasty for malignant causes of SVC syndrome is well established. However, there are limited data on their utility in SVC syndrome due to FM. We present two cases of SVC syndrome due to FM treated with endovascular stenting and a detailed review of current literature on its utility in SVCS due to benign causes.

Keywords: chronic venous disease; endovascular stent; fibrosing mediastinitis; superior vena cava syndrome; vascular complications.

PubMed Disclaimer

MeSH terms

Supplementary concepts